Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of highly palatable food (HPF). These episodes represent a central feature of binge eating disorder (BED), in which one of the mechanisms underlying the pathophysiology in the central nervous system is represented by the disruption of the dopamine (DA) rewarding circuitry. The endogenous satiety signal Oleoylethanolamide (OEA) has recently emerged as a potential novel pharmacological target for controlling eating disorders. In the present study we aim to investigate the effect of OEA on HPF intake and on the modulation of DA release in the nucleus accumbens (NAcc) in a model of BED. We used a BED model in which female rats with a history of int...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge-eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge-eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating episodes are characterized by uncontrollable, distressing eating of a large amount of h...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacothe...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED), characterized by compulsive and uncontrollable overeating of highly pal...
Binge-eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Oleoylethanolamide (OEA), is an endogenous lipid, which, despite its structural and similar biosynth...
Binge eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...
Binge-eating disorder (BED) is the most frequent eating disorder, for which current pharmacotherapie...